Veriheal

APRIL 11, 2022

The final goal is to introduce medicinal cannabis products to the pharmaceutical drug market. Groff North America is proud to be producing research-grade marijuana, so we can continue growing the field of cannabis-based medicine,” reads an official statement from the company’s website. “You This means that U.S.

Pharmaceutical 104

Pharmaceutical Research and Development DEA Clinical Trials 104

Veriheal

JULY 26, 2023

Georgia medical cannabis patients will soon have greater access to treatment as cannabis oil will be sold in many more pharmacies. Eligible patients registered with the state’s Department of Public Health can purchase cannabis oil from Georgia’s independent pharmacies.

Oil 98

Oil Patients Access THC 98

Veriheal

JANUARY 10, 2022

Of this amount, as many as 43,600 sufferers will eventually lose their lives despite undergoing treatment for the disease and its debilitating symptoms. Conventional methods of treatment for breast cancer—including chemotherapy—are known for causing a plethora of unwanted side effects. Breast Cancer Patients and Medical Cannabis.

Patients 98

Patients Treatment Medicine Consumption 98

Veriheal

MAY 25, 2023

We’re talking about ketamine —a dissociative anesthetic that is featured on the World Health Organization’s List of Essential Medicines. Also known as “K,” “special K,” or “cat-valium,” ketamine is gradually climbing out of an abyss of K-fueled house parties and into the vortex of medicine.

Medicine 98

Medicine Blood Pressure Therapy Clinical Trials 98

PrestoDoctor

DECEMBER 12, 2023

Cannabis as an Alternative Medicine Understanding the science behind cannabis and its medicinal properties More seniors are choosing cannabis as an alternative to traditional medications, and for good reason. The key lies in understanding the science behind cannabis and its medicinal properties.

Medicine 98

Medicine Chronic Pain Consumption Pharmaceutical 98

Project CBD

OCTOBER 26, 2023

I advise my patients to stop using cannabis for 36 to 48 hours prior to chemotherapy and to start again 36 to 48 hours after their session. Phase 2 is the first study level conducted on patients with the disease for which the drug is intended and determines whether it is safe and effective.

Research and Development 343

Research and Development Cannabinoids Terpenes Pharmaceutical 343

Cannabis Law Report

AUGUST 12, 2022

. – August 11, 2022) – MOTAGON, a pharmaceutical company based in Prague and specializing in medical cannabis, has secured a ground-breaking agreement with Europe’s biggest indoor cannabis producer and one of the first cannabis extracts and formulations producers PHCANN INTERNATIONAL. ”

Extraction 52

Extraction Pharmaceutical Patients THC 52

Veriheal

FEBRUARY 21, 2023

As medicinal and recreational cannabis legalization continues to sweep across the United States, a recent study paints a concerning portrait of many states denying or restricting medical marijuana (MMJ) access. How Do MMJ Restrictions Affect Patients and Doctors? Many patients take MMJ for more reasons than one.

Access 98

Access Patients Chronic Pain Conditions 98

Veriheal

AUGUST 12, 2021

Patients who suffer from epilepsy , which affects some 3.4 Funded by Realm of Caring —a non-profit organization committed to redefining cannabis through research and education—this study on CBD and epilepsy was carried out as part of a joint effort with Johns Hopkins University School of Medicine researchers.

Epilepsy 66

Epilepsy Pharmaceutical Patients Sleep 66

Cannabis Law Report

DECEMBER 23, 2021

DUBLIN–(BUSINESS WIRE)– “The Pharmaceutical Cannabis Report: 2nd Edition” report has been added to ResearchAndMarkets.com’s offering. Research on the endocannabinoid system is one of the most promising avenues for new therapeutics in medicine at the moment. GW Pharmaceuticals. Companies Mentioned.

Pharmaceutical 96

Pharmaceutical Clinical Trials Research and Development Cannabinoids 96

Cannabis Law Report

DECEMBER 11, 2021

A Manchester MP’s bid to open up cannabis treatments on the NHS has been blocked by Tory backbenchers in the House of Commons. 'A Despite the Government legalising medicinal cannabis in 2018, following a number of high-profile campaigns, thousands of people are still being denied access to the treatment. Read more at.

Treatment 52

Treatment Access Patients Medicine 52

Cannabis Law Report

JUNE 24, 2021

Luxembourg is scrambling to secure a new medical cannabis supplier after encountering delays of up to 60 days, leaving new patients empty-handed. Health minister Paulette Lenert (LSAP) responded to a parliamentary question that the country was facing three types of medicinal cannabis bottlenecks. Complementary therapy.

Medicine 104

Medicine Chronic Pain Treatment Patients 104

FloridaMarijuana.net

AUGUST 15, 2018

Living with PTSD, no matter the underlying cause of the trauma, can be extremely difficult for patients and their loved ones. Treatment usually aims at reducing reactions and to diminishing the acuity of the reactions. The post Medical Marijuana Offers Hope for Treatment of PTSD appeared first on.

Treatment 182

Treatment Marijuana Research and Development Therapy 182

MGC Pharma

FEBRUARY 15, 2018

What will unrestricted access to Medicinal Cannabis look like in Australia? A word from Ron Lipsky, Manager of Business Development and International Relations at MGC Pharmaceuticals Right now in Australia, access to Cannabis-based treatments is heavily restricted. kg of CBD and 163.7

Access 100

Access Medicine Chronic Pain Research and Development 100

MMJ Recs

MAY 23, 2024

Treatments for chronic conditions are hard as many individuals grapple with ongoing health issues and often find themselves in a perpetual search of what works to manage symptoms and find relief. However, for many individuals, these conventional treatments may fall short of providing adequate relief or come with undesirable side effects.

Conditions 105

Conditions Chronic Pain Therapy Marijuana 105

Kind Meds (Cannabis Education Blog)

SEPTEMBER 1, 2020

One of the biggest areas of contention in the public debate about cannabis legalization is the viability of medicinal cannabis as a treatment for many mental health disorders, such as anxiety, depression, bipolar disorder, schizophrenia, and others. Cannabis Is a Unique Substance and Treatment Method.

Treatment 122

Treatment Research and Development CBD THC 122

Project CBD

SEPTEMBER 12, 2023

Medicine in a Can A total of 15 patients with different incurable ailments would enroll in the Compassionate IND Program to study cannabis before it was officially shut down in 1992. He would undergo a dozen surgeries and consume a steady diet of prescription narcotics and other pharmaceuticals.

Chronic Pain 228

Chronic Pain Treatment Cannabinoids Research and Development 228

Cannabis Law Report

SEPTEMBER 28, 2021

In this case, the patient needs to look for the best ways to treat pain and improve their life quality. Acupuncture is one of the safest alternative forms of treatment for chronic pain. Ideally, it should be used in combination with other therapies, such as herbal medicine and massage, and can be a great addition to other treatments.

Treatment 52

Treatment Chronic Pain Therapy Tincture 52

Veriheal

SEPTEMBER 23, 2021

Fortunately, one such man, Levi Barker, provided us with some much-needed insight into what the substance is, how it is used in treatment, and more. Veriheal: How did you first get into botanical medicines and come to heal at the Iboga Wellness Center? It is then time to allow the medicine to go in and work and do its job.

Treatment 98

Treatment Medicine Research and Development Therapy 98

Veriheal

SEPTEMBER 18, 2020

Conventional forms of treatment are often accompanied by adverse side effects but there is hope for effective treatment with fewer side effects. . million of NWS Health funding for their Cannabinoid Therapeutics and Brain and Mind Centre to see if cannabidiol can be that effective treatment for spinal cord injury.

Treatment 98

Treatment Chronic Pain Research and Development CBD 98

Cannabis Law Report

SEPTEMBER 24, 2019

Here is the BBC report and below you will find the full press release from GW Pharmaceuticals. T he EU has approved for the first time the use of a medicinal cannabis product aimed at patients with two rare, but severe, forms of childhood epilepsy. There are some other cannabis-based medicines that are licensed in the UK.

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

Puff Puff Post

SEPTEMBER 25, 2019

Researchers across North America have been conducting studies on the effectiveness of Multiple Sclerosis treatment through cannabis. Currently, there is no cure for MS , and people are seeking alternative methods outside of standard pharmaceuticals and physical therapy to help treat their various symptoms. million in 2008 to 2.3

Treatment 100

Treatment Research and Development Pharmaceutical THC 100

Cannabis Law Report

AUGUST 17, 2021

reduction in 28-day seizure frequency relative to baseline in tuberous sclerosis complex (TSC) patients (n=23). reduction was observed in focal seizures (n=19), the most common seizure type in TSC patients. Phase 3 planning for TrustTSC trial ongoing with first patient expected to be enrolled in Q4 2021. RADNOR, Pa.–(BUSINESS

Pharmaceutical 98

Pharmaceutical Clinical Trials Treatment Patients 98

Cannabis Info

MARCH 2, 2019

Marijuana as a treatment for epilepsy. Medical cannabis is showing great potential in the treatment of epilepsy. Cannabis has been used medicinally for thousands of years by the human race for a large catalogue of ailments. Epilepsy is usually diagnosed after patients have experienced a series of seizures.

Epilepsy 69

Epilepsy Treatment Marijuana Research and Development 69

Kind Meds (Cannabis Education Blog)

NOVEMBER 18, 2020

In either case, there is definitely a connection, and the widening availability for adults to consume cannabis legally for recreational and medicinal purposes has driven public interest into using cannabis for mental health treatment. Between CBD and THC, CBD seems to hold the best potential as a treatment for anxiety compared to THC.

Treatment 111

Treatment Conditions CBD Clinical Trials 111

Puff Puff Post

MARCH 10, 2020

SOURCE InMed Pharmaceuticals Inc. InMed has conducted preclinical pharmacology studies that suggest CBN in INM-755 may help relieve hallmark EB symptoms, including inflammation and pain, as well potentially restore the integrity of the skin in a subset of EB Simplex patients. For more information, visit www.inmedpharma.com.

Clinical Trials 84

Clinical Trials Pharmaceutical Research and Development Cannabinoids 84

Cannabis Law Report

JUNE 23, 2021

COPENHAGEN , June 22, 2021 /PRNewswire/ — Valcon Medical A/S (“Valcon Medical” or the “Company”), Denmark’s leading independent cannabis concentrate and medical formulation provider, received its licensing for the commercial production of cannabis from the Danish Medicines Agency (DKMA) earlier in May 2021.

Pharmaceutical 86

Pharmaceutical Concentrates Extraction Medicine 86

United Patients Group

APRIL 18, 2023

It’s also a medicine, and it can be used for recreational purposes as well. Because they often combine it with other drugs like cocaine or heroin or even legal ‘prescribed’ pharmaceuticals–and those are far more dangerous than cannabis itself! Myth: Cannabis is just a drug. Cannabis is a plant.

Research and Development 110

Research and Development Indica Treatment Conditions 110

CannaTech

JANUARY 16, 2019

Thanks to the recent emergence of regulated medical cannabis markets, the success of this versatile plant can be followed from farm to pharma and prescriber to patient, however, the origins of cannabis as medicine cannot be as simply traced as the plant is today from seed to sale. It is not a story about profiting off of people.

Access 89

Access Patients Pharmaceutical Education 89

Cannabis Law Report

MARCH 19, 2022

publishers announces the launch of Psychedelic Medicine , an influential and dynamic peer-reviewed journal supporting the growing influential research and clinical applications in this pivotal field. For further information or submission inquiries about Psychedelic Medicine , please contact us. Mary Ann Liebert Inc.,

Medicine 52

Medicine Decriminalization Pharmaceutical Topical 52

Cannabis Law Report

AUGUST 10, 2022

David Pidduck , CEO, MediPharm Labs commented, “We are proud to participate in this important research that further solidifies our pharmaceutical approach to medical cannabis. Dementia and related indications are hard to treat for patients and caregivers especially at the end-of-life stage. MediPharm Labs Corp.

Clinical Trials 52

Clinical Trials Medicine Pharmaceutical THC 52

Cannabis Law Report

SEPTEMBER 22, 2022

List Medicinal Cannabis on the PBS. The Federal Parliament legalised the use of medicinal cannabis products in Australia in February 2016, but access to treatment is still severely limited due to cost, with patients reporting average monthly costs in excess of $300 , or approximately $10 per day.

Pharmaceutical 52

Pharmaceutical Media Medicine Treatment 52

Cannabis Law Report

MAY 2, 2023

Australian cannabis company Cannatrek has launched a not-for-profit organisation dedicated to providing support and access to medicinal cannabis therapies for vulnerable groups. Medicinal cannabis is still quite expensive, […]

Therapy 52

Therapy Pharmaceutical Medicine Treatment 52

Cannabis Law Report

JUNE 28, 2021

Pharmaceutical and Medical Cannabis Leaders Zambon GmbH and Adven GmbH will Drive Medical Cannabis Supporting Treatments for Neurological Therapies. The aim of the agreement is to make medical cannabis treatments available to patients, with an initial focus on neurological therapies.

Access 105

Access Research and Development Pharmaceutical Therapy 105

FloridaMarijuana.net

AUGUST 16, 2018

Dementia cannot be confirmed until a patient is deceased. Dementia is hard on the patient, and often harder on the family or caregivers. The Dementia Society of America attributes Dementia to rising healthcare costs as billions are spent each year for treatments and research. It is caused by physical changes in the brain.

Clinical Trials 184

Clinical Trials Marijuana Patients Pharmaceutical 184

NORML

JULY 1, 2019

Three new laws intended to expand patient access to and the therapeutic value of Virginia’s medical cannabis program take effect July 1, 2019. “These bills help ensure that all patients are able to obtain and use the necessary therapeutic doses of their cannabis medicines regardless of location or physical ability.”

Law 257

Law Patients Access Oil 257

Sensi Seeds

JANUARY 4, 2019

Context of the Medicinal Cannabis Situation. Since 2001, Canadians seeking to use cannabis for medical treatment have had access to it under the Marihuana Medical Access Regulations (MMAR ). Patients should first meet with a health-care practitioner to determine if cannabis can be beneficial in treating their symptoms.

Medicine 75

Medicine Research and Development Patients Programs 75